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Abstract 
 
 Cardiovascular diseases (CVD) are the major cause of morbidity and mortality worldwide. The 
consumption of healthy diets rich in polyphenols has been inversely associated with the 
development of CVD. This study evaluated the effects of green coffee bean (GCBE) and yerba 
mate (YMPE) phenolic extracts, the main phenolic and methylxanthines constituents (5-
caffeoylquinic acid, 3,5-dicaffeoylquinic acid, caffeine, and theobromine), and their main 
metabolites (caffeic acid, ferulic acid, dihydrocaffeic acid -DHCA- and dihydroferulic acid -DHFA-) 
on platelet activation in vitro. Upon incubation with different doses (0.01 – 100 µg/mL or µM) of 
each compound, adenosine 5’-diphosphate-induced P-selectin expression and fibrinogen binding 
were determined using whole blood flow cytometry. Platelet P-selectin expression was significantly 
decreased by YMPE and all phenolic and methylxanthines constituents at physiological 
concentrations, compared with control, whereas fibrinogen binding on platelets was significantly 
increased. The colonic metabolites (DHCA and DHFA) had stronger inhibitory effects on P-selectin 
expression than their phenolic precursors, suggesting an increase in the efficacy to modulate 
platelet activation with the metabolism of the phenolic compounds.  
 
Running title: Colonic metabolites of yerba mate inhibit in vitro platelet activation  
 
Keywords: Green coffee; yerba mate; phenolic compounds; methylxanthines; metabolites; platelet 
activation. 
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Introduction 
 
Cardiovascular disease (CVD) is a main cause of mortality worldwide. The development of 
atherosclerosis and subsequent thrombus formation are believed to be the underlying reason of 
CVD.1 Consumption of certain dietary compounds lowers the risk of CVD.2,3,4 Indeed, consumption 
of various plant extract infusions was associated with cardioprotective effects in animal models and 
in humans.5,6,7 One such compound is yerba mate, a popular infusion originating from South 
America prepared from the dried leaves of Ilex paraguariensis. Due to its perceived 
hypocholesterolemic, anti-oxidant and anti-obesity activity, consumption of yerba mate is now 
spreading around the world.8 In addition, various studies have shown that moderate intake of 
coffee may have cardioprotective effects,9,10,11 questioning the negative effects on vascular 
function traditionally associated with coffee consumption. 
Yerba mate and coffee are a rich source of different bioactive compounds, especially 
cinnamoylquinic acids and methylxanthines (Figure 1). Cinnamoylquinic acids, collectively known 
as chlorogenic acids (CGA),12 are a family of esters formed between quinic acid and one or more 
trans-cinnamic acids (p-coumaric, caffeic, ferulic, sinapic or dimethoxycinnamic acid). 
Caffeoylquinic and dicaffeoylquinic acids isomers (Figure 1a) represent 80-90% of total CGA in 
green coffee and yerba mate.13,14 Methylxanthines are natural purine alkaloids including caffeine, 
theophylline and theobromine (Figure 1b), with caffeine being the most abundant in both 
beverages.15,16,17 
Physiological effects of dietary compounds are potentially limited by the bioavailability and 
biotransformation of their bioactive components in the organism. CGA are absorbed and 
metabolized in the stomach, small and large intestine (Figure 2), and their bioavailability depends 
on the ingested dose.18 Plasma concentrations of 5-caffeoylquinic acid (5-CQA), the main CGA in 
green coffee and yerba mate, are low at 6 - 30 nM after consumption of roasted coffee,18,19 and 5.9 
µM after consumption of green coffee.20 In addition, plasma levels of 3,5-dicaffeoylquinic acid (3,5-
DCQA) have been reported to be as high as 2.5 µM after the intake of a green coffee extract,20 
although most studies suggested the hydrolysis of 3,5-DCQA to monoacylquinic acid as the main 
biotransformation pathway.18,19 Caffeic (CA) and ferulic (FA) acids are the main early metabolites, 
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with plasma levels from 0.08 to 1.1 and from 0.14 to 0.8 µM, respectively, after intake of roasted 
and green coffee.20,21 Nevertheless, the main metabolites from CGA are dihydrocaffeic (DHCA) 
and dihydroferulic (DHFA) acids, produced by the microflora in the large intestine. These 
metabolites are found in plasma at levels up to 0.7 and 1 µM, respectively, 5 - 10 h after intake of 
400 mL of coffee containing approximately 600 mg CGA.19 On the contrary, caffeine is quickly and 
completely absorbed in the small intestine and transported to the liver where it is metabolized into 
the dimethylxanthines paraxanthine, theobromine and theophylline, which are further metabolized 
to monomethylxanthines.22 Previous studies have shown that plasma levels of caffeine can 
increase to 2 - 12 µM, and theobromine can increase to 0.5 - 16 µM, after intake of 9.9 - 70 mg of 
caffeine and 0.2 - 84 mg of theobromine, respectively, which are present in 3.5 g of coffee and 15 
g of cocoa.23,24 
Roasting of green coffee beans causes significant degradation and/or transformation of 
polyphenols, affecting the physical and chemical properties of roasted coffee beans,14,25,26 and 
causing a loss of its antioxidant 27 and anti-inflammatory capacity in animal models.28 Moreover, 
the consumption of green coffee has been associated with a lower risk of cancer and CVD 29 and 
may therefore be a healthier alternative to roasted coffee. 
One possible mechanism by which these dietary compounds may lower CVD risk is by 
modulation of platelet function.30 Activated platelets are involved in the formation of blood clots to 
stop bleeding and heal wounds.31 However, excessive platelet activation has been associated with 
both the physical blocking of blood vessels as well as the development of chronic inflammation. 
Therefore, platelet activation has been proposed as an independent risk factor of CVD.32 Platelet 
function can be beneficially modulated by different dietary compounds, such as those found in 
garlic, onions, kiwi, olive oil, chocolate and mushrooms.33,34,35,36,37 In this study we assessed the 
effects of green coffee bean (GCBE) and yerba mate (YMPE) phenolic extracts, the main 
methylxanthines and phenolic constituents, caffeine, theobromine, 5-CQA, 3,5-DCQA, including 
their main metabolites (CA, FA, DHCA and DHFA), on activation of human platelets in vitro.  
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2. Material and methods 
 
Reagents 
Green coffee (Coffea arabica L. from Colombia) and yerba mate (Ilex paraguariensis L.) were 
purchased in a local supermarket in Madrid (Spain). 3,5-DCQA was acquired from PhytoLab 
(Vestenbergsgreuth, Germany). Caffeine was obtained from Fluka (Madrid, Spain). 5-CQA, CA, 
FA, theobromine, DHCA, DHFA were obtained from Sigma-Aldrich (Madrid, Spain). Phycoerythrin 
(PE)-conjugated mouse anti-human CD61 (CD61-PE), allophycocyanin (APC)-conjugated mouse 
anti-human P-selectin (CD62-APC), PE-conjugated mouse IgG1κ, APC-conjugated mouse IgG1κ, 
AF488-conjugated mouse IgG1κ, sodium chloride (NaCl) and FACS Flow sheath fluid were 
acquired from BD Biosciences (Oxford, UK). AF488-conjugated fibrinogen from human plasma 
was obtained from Fisher Scientific (Loughborough, UK). Adenosine 5`-diphosphate (ADP), 
phosphate-buffered saline (PBS), dimethylsulfoxide (DMSO), potassium chloride (KCl), 
magnesium sulfate heptahydrate (MgSO4-7H2O), 4-(2-hydroxyethyl)-1-piperazineethanesulphonic 
acid (HEPES), phorbol 12-myristate 13-acetate (PMA) and quercetin were acquired from Sigma-
Aldrich (Dorset, UK). All other chemicals were of analytical grade. 
 
Green coffee bean (GCBE) and yerba mate (YMPE) phenolic extracts and pure compound 
preparation   
Soluble phenolic compounds were prepared extracted in triplicate according to Bravo and 
Calixto38 and characterized as previously described.39 Briefly, 1 g of green coffee beans, previously 
ground and sieved to 0.5 µm particle size, and dried leaves of yerba mate, were washed once with 
2 N hydrochloric acid in aqueous methanol (50:50, v/v, 1 h at room temperature, constant shaking) 
followed by acetone:water (70:30, v/v, 1 h at room temperature, constant shaking). After each 
extraction step, the samples were centrifuged (10 min, 3000 g) and the supernatants combined. 
The organic solvents were evaporated under reduced pressure with a rotavapor and the phenolic 
extracts were lyophilized. 
The main phenolic and methylxanthine compounds of both extracts were analyzed as 
previously described40,39 using a Superspher 100 RP18 column (4.6 x 250 mm, 4 µm; Agilent 
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Technologies) and an Agilent 1200 series liquid chromatographic system equipped with an auto-
sampler, quaternary pump, diode-array detector and quadrupole mass spectrometer (Agilent 
Technologies, Germany). Chromatographic analysis showed that the main constituents of both 
extracts were mono- and dicaffeoylquinic acids (80% and 8% of the total phenolic content of GCBE 
and 65% and 18% for YMPE, respectively). YMPE also contained up to 10% of feruloylquinic acids 
and other cinnamoylquinic acids, as well as over 9% of flavonol-glycosides. Caffeine was the major 
methylxanthine in both extracts (up to 95% of total alkaloids and less than 10% of total 
compounds).40,39 
GCBE and YMPE powder and the pure standards were dissolved in 100% DMSO at 100 mg/mL 
and 100 mM, respectively, and diluted with PBS to prepare working dilutions for incubation with 
whole blood at 0.01, 0.1, 1, 10, 20, 50 and 100 µg/mL and µM (final concentration in 0.1% DMSO 
in blood). 
 
Blood sample collection 
Blood sampling for testing the in vitro effects of dietary compounds on platelet function was 
approved by the Rowett Human Studies Ethical Review Panel, Aberdeen, Scotland, United 
Kingdom and the experiments were carried out in accordance with the ethical principles of the 
Declaration of Helsinki and Good Clinical Practice. Eligible volunteers were 20 - 70 years old, 
healthy, non-smokers, not suffering from chronic pathologies, had abstained from any medication 
or dietary supplements that affect platelet function and had not given blood for transfusion 
purposes within the previous month. We included volunteers who had normal platelet function as 
assessed for previously executed in vitro platelet function experiments.  
Venous blood samples were taken from a group of 15 healthy men and women after an 
informed consent was obtained as described previously.41 Volunteers were allowed to continue 
their habitual diet but were asked to fast for at least 10 h before the blood sampling including to 
abstain tea and coffee consumption. Multiple blood donations were separated by at least four 
weeks to allow recovery of platelet counts. Blood samples were collected using a siliconized 21 
gauge butterfly needle and closed s-monovette blood collection tubes containing 1 mL trisodium 
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citrate (0.106 mol/L) as anticoagulant (Sarstedt, Beaumont Leys, UK) with the pressure of the 
tourniquet released before blood was drawn. The first 5 ml of blood were discarded.  
 
Assessment of platelet activation markers by flow cytometry 
P-selectin expression and fibrinogen binding was assessed with flow cytometry in diluted whole 
blood after pre-incubation with compounds on a 96-well plate as described previously with 
modifications. 42 Briefly, blood was diluted 1:10 in HEPES-Mg buffer and platelets were allowed to 
rest for 10 min before incubation with the compounds (final concentration 0.01, 0.1, 1, 10, 20, 50 
and 100 µM for pure standards and µg/mL for GCBE and YMPE) for 10 min in duplicate. Platelet 
activation was subsequently initiated with 10 µM ADP (final concentration) for 10 min followed by 
incubation for 20 min with PE-CD61, APC-CD62 and AF488-fibrinogen. All incubations were done 
at room temperature. The reaction was stopped by addition of cold (4°) PBS and the samples were 
measured using a BD FACS Calibur (BD Biosciences, Oxford, UK) and an Automated 
Microsampling System (Cytek Development Inc., Ely, UK) within 6 h of sampling. 0.1% 
DMSO/PBS, 1 µM PMA and 10 and 25 µM quercetin in 0.1% DMSO/PBS final concentration were 
used as control, positive control marker in the flow cytometry and positive control of compounds, 
respectively. The layout of the 96-well plate was as follows: each compound was analyzed in 
columns with an individual control at the top of each set (with five sets per plate) whereas the 
duplicate of each compound/concentration combination was measured in rows. The order of the 
sets in which the compounds were measured but not the concentrations were randomized between 
plates.  Acquisition of cells were stopped when 10000 cells were detected in the platelet gate or 
after 75 seconds whichever came first.  In case of a time out, data were accepted as valid when 
more than 8000 platelet events per sample were detected. 
 
Statistical analysis   
GenStat version 13 (VSN International, UK) was employed for the statistical analysis of data. A 
mixed model was fitted using residual maximum likelihood (REML) without adjustment for missing 
values. Significance of treatment effects was tested by the Wald statistic, with estimated degrees 
of freedom in the denominator after treatment with compounds adjusted for control. Fixed effect 
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terms were: plate, volunteer, set, compound and concentration. Volunteer, plate and set were 
defined as random effect terms. Data are presented as percentage of change of adjusted mean ± 
SED compared with control. The percentage of change was calculated as follows ((adjusted mean 
compound – adjusted mean control)/adjusted mean control)*100. The adjusted means and SED of 
adjusted means were calculated as part of the REML analysis. Results were considered significant 
when difference of adjusted mean with control was higher than 2 x standard error of difference 
(SED).  
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Results 
 
Effect on P-selectin expression 
Incubation with 10, 20 and 50 µg/mL YMPE significantly decreased ADP-induced P-selectin 
expression by 10.5%, 8.5% and 6.0%, respectively compared with a 0.1% DMSO/PBS control. 
Contrary, incubation with 100 µg/mL YMPE and 50 and 100 µg/mL GCBE significantly increased 
ADP-induced P-selectin expression (Figure 3a and Table 1 from supporting information). 
Incubation with the mayor compounds present in yerba mate and green coffee beans (Figure 3a 
and Table 1 from supporting information) showed a high capacity to decrease ADP-induced P-
selectin expression. Incubation with 1, 10 and 20 µM 5-CQA reduced ADP-induced P-selectin 
expression by 7.5%, 7.6% and 8.3%, respectively; 10 and 20 µM 3,5-DCQA decreased ADP-
induced P-selectin expression by 8.0% and 6.7%, respectively; 20, 50 and 100 µM caffeine 
decreased ADP-induced P-selectin expression by 5.8%, 8.0% and 8.0%, respectively; and 1 to 100 
µM theobromine decreased ADP-induced P-selectin expression by 6.4%, 11.3%, 12.9%, 8.9% and 
8.2%, respectively. However incubation with 0.01 µM 5-CQA and 0.01 µM caffeine significantly 
increased ADP-induced platelet P-selectin expression by 7.2% and 6.3%, respectively compared 
with control. Finally, ADP-induced P-selectin expression, compared with 0.1% DMSO/PBS control, 
was significantly lower after incubation with the main metabolites from yerba mate and green 
coffee at different concentrations: 20 µM CA by 8.6%, 10 to 100 µM FA by 5.3%, 7.4%, 8.4% and 
9.9%, 1 to 100 µM DHCA by 7.7%, 10.6%, 13.5%, 10.7% and 7.7%, and 10 and 20 µM DHFA by 
6.3% and 10.6%, respectively. Contrary incubation with 0.01 µM FA significantly increased ADP-
induced P-selectin by 6.3%. 
 
Effect on fibrinogen binding  
Fibrinogen binding was generally increased after incubation with compounds, compared with 
control (Figure 3b and Table 2 from supporting information). Incubation with YMPE, GCBE, 5-CQA 
and CA across all concentrations significantly increased ADP-induced fibrinogen binding from 
3.4% after 10 µM 3,5-DCQA and 10 µM DHCA to 17.0% after 100 µg/ml GCBE.
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Discussion  
 
In this study, we have shown that the crude phenolic extracts of green coffee beans and yerba 
mate, as well as their main compounds and metabolites, were effective in modulating agonist-
induced platelet activation markers in vitro. Platelets play an essential role maintaining hemostasis 
upon vascular damage, recognizing exposed connective tissue components from endothelial cells, 
such as collagen or von Willebrand factor. P-selectin is one of the first molecules released from α–
granules in platelets, so its expression on the surface is commonly used as an early marker for 
platelet activation.31,43  
The intake of green coffee and yerba mate has been associated with a lower risk of CVD due to 
its anti-hypertensive effect and capacity to reduce blood viscosity.44,45,46 Moreover, the results of 
this study demonstrated, for the first time, a potentially beneficial effect of YMPE at physiological 
concentrations on the modulation of platelet activation by reducing ADP-induced P-selectin 
expression. The anti-platelet effects of these compounds are similar to those shown for other 
bioactive plants, specifically fruits and vegetables with a high phenolic content, such as strawberry 
or grape. Such compounds inhibit ADP- and arachidonic acid-induced platelet aggregation at 
concentrations of 100 - 1000 µg/mL, and thrombin receptor activating peptide (TRAP)- and 
thrombin-induced platelet activation and aggregation at 1.2 - 50 µg/mL, respectively.47,48,49 
However, whilst these studies showed modulation of platelet function for a large range of 
concentrations, i.e. 1 to 1000 µg/mL, we found that ADP-induced P-selectin expression was 
increased rather than reduced when platelets were incubated with high concentrations of GCBE 
and YMPE, i.e. 50 and 100 µg/mL. Our results suggest that the beneficial effects of YMPE are only 
present at lower concentrations, which may be observed in the blood stream, and that higher, pro-
oxidant concentrations of these compounds may possibly have detrimental effects on platelet 
function.  
Traditionally, methylxanthines have been associated with negative effects on health due to their 
stimulatory properties on the central nervous system. However, recently many studies have 
focused on understanding some of the molecular mechanisms of methylxanthines, associating 
their moderate consumption with neuroprotective, hypoglycemic, anti-inflammatory or 
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cardiovascular protector effects. 50,51,52 In this study we show, for the first time, an important role of 
methylxanthines on modulation of platelet function. Previous studies have evaluated the effect of 
300 - 600 mg orally administered caffeine on human platelet function.53,54 These studies showed 
that only when caffeine was administered after clopidogrel treatment (a typical treatment as part of 
coronary stenting), enhanced platelet inhibition could be observed, whilst caffeine itself had no 
significant effect on ADP- and collagen-induced platelet aggregation or activation in caffeine-
treated subjects compared with a placebo group. However, caffeine significantly decreased in vitro 
ADP-induced P-selectin expression at equivalent plasma concentrations, yet, the effect may be 
small. In contrast, physiologically relevant theobromide concentrations (i.e. 10 and 20 µM), which 
are found in plasma after intake of a methylxanthines-rich cocoa, 24 reduced ADP-induced P-
selectin expression.  
On other hand, polyphenols have been also associated with a number of beneficial effects on 
health, such as anti-carcinogenic, anti-inflammatory, antioxidant, and also anti-platelet activity.55,56 
However, these beneficial effects could be limited by their bioavailability which is lower than 
methylxanthines, with phenolic plasma concentrations lower than 10 µM, depending of the degree 
of roasting and the consumed dose of coffee.18,20 The results of this study showed a significant 
effect of 5-CQA on the modulation of platelet activation at 1 - 20 µM, close to concentrations found 
in plasma after intake of green coffee extract (6 µM).20 On the contrary, much higher doses of 3,5-
DCQA, the other main polyphenol in green coffee and yerba mate, are needed (10 - 20 µM) in 
order to significantly decrease ADP-induced P-selectin expression, much higher than the maximal 
plasma concentration (2.5 µM) reported for this compound.20 This may be due to the higher 
molecular weight of 3,5-DCQA, making it more difficult to pass the platelet membrane. With 
respect to the metabolites of 5-CQA and 3,5-DCQA, only DHCA showed the ability to significantly 
modulate platelet activation at 1 µM, the maximal plasma concentration found after coffee intake.18 
We found that the colonic metabolites DHCA and DHFA significantly decreased P-selectin 
expression in ADP-stimulated platelets at 10 µM, with others showing a trend to decreased P-
selectin expression on platelets activated by TRAP after incubation with DHCA.57 On the contrary, 
concentrations of at least 100 µM were necessary to inhibit the expression of TRAP- and ADP-
induced P-selectin by the early metabolites CA and FA, and 5-CQA, respectively,42,58 while the 
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results of this study showed a significant decrease of ADP-induced P-selectin expression at 
noticeably lower concentrations (20, 10 and 1 µM for CA, FA and 5-CQA, respectively), indicating 
that the colonic metabolites may have an even stronger effect on platelet function than their 
phenolic precursors. Early metabolites from CGA appear at 1 - 2 h after coffee intake, and have a 
short life time of approximately 30 min,21,59 whereas DHCA and DHFA appear in the circulation 5 - 
10 h after consumption and their life time is between 0.7 and 2.1 h.19 A longer circulation time of 
colonic metabolites, together their higher effect on platelet function, suggest that these colonic 
metabolites may be the main contributors to the beneficial effect of CGA-rich foods on human 
platelet function. The differences in efficacy could relate to their molecular structure. Indeed, our 
previous data have suggested that the very simple phenolic structures are more likely to show anti-
platelet effects.42 On the contrary, the early metabolite CA originating in the small intestine showed 
less effect than its 5-CQA precursor, while the microbial metabolite DHCA was more effective, 
suggesting that the reduction of some cinnamic acids could be favoring their anti-platelet effect. 
Therefore, this study confirms the capacity of CGA and overall their metabolites, at physiological 
concentrations, to modulate P-selectin expression on platelets. This effect is probably due to its 
cinnamic acid molecules, which have been associated with a reduction in the expression of P-
selectin in previous studies, whilst quinic acid have not shown any of these effects.60,61 However, 
the underlying mechanisms of the anti-platelet effects of polyphenols are not clear.  
There are only few publications about the bioavailability of yerba mate compounds. The daily 
intake of yerba mate is approximately 100 g infused in 2 liter, being traditionally consumed in single 
mouthfuls throughout the day and not per coup.8 We recently showed that a single serving could 
be prepared from 5 g yerba mate in 250 mL water, containing approximately 400 mg CGA (5 mM) 
from which up 800 nM would be reported in plasma after their intake.62 In comparison, a single 
serving of espresso coffee provides between 24 - 422 mg of CGA and 51 - 322 of caffeine, 
corresponding to approximately 6 - 12 mM CGA and 8 - 16 mM caffeine depending on the type of 
roast and the volume consumed.63 In the studies about the bioavailability of coffee phytochemicals, 
plasma levels up 1.5 µM CGA and 13 µM methylxanthines have been reported after the intake of 
coffee beverages providing 2 - 4 mM CGA and 1 mM methylxanthines,19,21,23 with higher plasma 
concentrations of CGA (up to 10 µM) reported after the intake of roasted coffee.64 
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 Based on previous results,40,39 the highest dose tested of phenolic extracts was 100 µg/mL in 
the present study, corresponded to approximately 200 µM CGA and 50 µM methylxanthines; 
however, the doses tested for phenolic extracts ≤ 1 µg/mL would be within the physiological range 
for CGA (equivalent to approximately ≤ 2 µM CGA), while all tested concentrations would be 
physiological for methylxanthines. In comparison, methylxanthines as well as polyphenols and their 
metabolites have a similar ability to modulate platelet activation by reducing the expression of 
ADP-induced P-selectin as quercetin at the same range of concentrations (Table 1 from supporting 
information).  
Unexpectedly, the binding of fibrinogen onto platelets was significantly increased by the majority 
of compounds, compared with control. However, only the effect of the highest concentrations of 
phenolic extracts (20 - 100 µg/mL GCBE and 100 µg/mL YMPE) induced a >10% change versus 
control. In contrast, incubation with quercetin significantly decreased the binding of fibrinogen in 
ADP-stimulated platelets (Table 2 from supporting information). The activation of the platelet 
integrin glycoprotein IIb/IIIa (αIIbβ3) receptor is one of the last steps in the process of full platelet 
aggregation. The signaling cascade that initiates platelet activation allows the conformational 
change of this receptor. The transformation from a quiescent to an activated conformation of the 
receptor permits the interaction with soluble fibrinogen, which plays an important role in 
maintaining the stability of a thrombus.31,65 However, the activation of integrin αIIbβ3 receptor may 
involve other receptors or molecules not directly related to platelet activation, such as the cMpl 
receptor, tyrosine kinases or GTPasa Rap1b.66 Thus, polyphenols and methylxanthines from green 
coffee and yerba mate and to lesser extent their main metabolites, may be able to indirectly 
increase the ADP-induced binding of fibrinogen to integrin αIIbβ3 via such receptors or molecules.  
Furthermore, platelets also express the integrin αVβ3 which shares several ligands with αIIbβ3, 
including fibrinogen and von Willebrand Factor.67 Based on the results, we cannot exclude the 
possibility that the tested compounds interfered with the binding of these other ligands and thus 
increased to probability for fibrinogen binding. Overall, it should be noted that the percentage 
increase of fibrinogen binding was lower compared with the percentage decrease in P-selectin 
expression. 
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One of the proposed mechanisms by which polyphenols affect platelet function is that they 
increase levels of cyclic adenosine monophosphate (cAMP), which inhibits P-selectin expression 
on platelets through activation of protein kinase A.68,69 Previous studies have demonstrated that 
polyphenols, such as caffeic acid, quercetin or epigallocatechin-3-gallate, act through this 
mechanism.70,71,72 Methylxanthines also have been associated with an increase of cAMP levels 
due to up-regulation of platelet Gs protein-coupled adenosine 2A receptor,53,54 which mediates the 
production of cAMP by adenylyl cyclase in platelets.73 Moreover it has recently been demonstrated 
that chlorogenic acid presents an active site to the adenosine 2A receptor, favoring the increase of 
cAMP levels and therefore an inhibition of platelet activation.58 Therefore, the decrease in ADP-
induced P-selectin expression by the tested polyphenols and methylxanthines in our study could 
be associated with an increase of cAMP levels in platelets mediated by adenosine 2A receptor. 
In conclusion, this study has shown, for the first time, the capacity of green coffee beans and 
yerba mate phenolic extracts to decrease ADP-induced P-selectin expression probably due to their 
phenolic and methylxanthine content, leading to a possible protective effect against CVD. 
Additionally, this cardio-protective effect could be strengthened in vivo by the action of the own 
colonic metabolites from the intake of both beverages. These results demonstrate that these 
compounds and metabolites have beneficial effects on human platelet function in vitro at 
physiological concentrations suggesting that continued exposition to physiological levels of CA, FA, 
DHCA or DHFA through moderate consumption of green coffee, yerba mate or CGA-rich foods 
may have beneficial health effects in vivo. 
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Figure Captions 
 
Figure 1. Structures of the main phenolic compound chlorogenic acids (a) and methylxanthines (b) 
found in green coffee and yerba mate. 
 
Figure 2. Schematic overview of chlorogenic acids metabolism in digestive tract after the intake of 
roasted and green coffee according to previously published studies.18-21 5-CQA, 5-caffeoylquinic 
acid; 3,5-DCQA, 3,5-dicaffeoylquinic acid; CA, caffeic acid; COMT, catechol-O-methyltransferase; 
DHCA, dihydrocaffeic acid; DHFA, dihydroferulic acid; EST, esterase; FA, ferulic acid; RA, 
reductase. 
 
Figure 3. Effects of green coffee, yerba mate and their main compounds on platelet activation 
markers. Diluted whole blood was incubated with 0.01 to 100 µg/mL of green coffee bean (GCBE) 
and yerba mate phenolic extracts (YMPE), 0.01 to 100 µM of caffeine (CAF) and theobromine 
(TB), 5-caffeoylquinic acid (5-CQA), 3,5-dicaffeoylquinic acid (3,5-DCQA), as well as caffeic (CA), 
ferulic (FA), dihydrocaffeic (DHCA) and dihydroferulic acids (DHFA). ADP-induced P-selectin 
expression (a) and fibrinogen binding (b) were measured as described in 2.4. Results are shown 
as percentage change of adjusted means compared with control (0.1% DMSO/PBS) ± SED (n ≥ 9). 
* p < 0.05.  
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